Related Experiment Video

Updated: May 11, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'

C Ho-Yen, R L Bowen, S Kermorgant

    British Journal of Cancer
    |May 16, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    Related Experiment Videos

    Last Updated: May 11, 2026

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    Related Concept Videos

    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cross-tissue immune cell analysis reveals tissue-specific features in humans.

    Science (New York, N.Y.)·2022

    A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuries.

    Journal of immunological methods·2021

    Risk factors for Toxoplasma gondii seropositivity in the Old Order Amish.

    Epidemiology and infection·2020

    The immunological response to traumatic brain injury.

    Journal of neuroimmunology·2019

    Day-case bilateral sagittal split osteotomy.

    The British journal of oral & maxillofacial surgery·2018

    Abnormalities of age-related T cell senescence in Parkinson's disease.

    Journal of neuroinflammation·2018

    Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.

    British journal of cancer·2026

    Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

    British journal of cancer·2026

    PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

    British journal of cancer·2026

    Radiomics as a spatial context for treatment decision-making in head and neck cancer.

    British journal of cancer·2026

    Triglyceride enhancs NSCLC metastasis via lipid β-oxidation by RhoA-driven cytoskeletal remodeling in ECM-constrained microenvironments.

    British journal of cancer·2026

    SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways.

    British journal of cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us